Current Challenges in Hematology

 

Current Challenges in Hematology
A

Emerging Targeted Therapies and Combinations in AML

By Current Challenges in Hematology FEATURING Adolfo de la Fuente
By Current Challenges in Hematology FEATURING Adolfo de la Fuente
78 views
February 21, 2023
0 Comments
Login to view comments. Click here to Login
1st Edition
17:23
Current Challenges in Hematology

2023 Updates on Sequencing in CLL

Feat. L. Scarfò
13:44
Current Challenges in Hematology

Current Updates in High-Risk AML

Feat. A. Isidori
17:35
Current Challenges in Hematology

MRD in AML: How Does it Guide Our Treatment Choices?

Feat. A. Venditti
18:43
Current Challenges in Hematology

Emerging Targeted Therapies and Combinations in AML

Feat. A. de la Fuente
07:10
Current Challenges in Hematology

IDH1-Mutated AML Patient Case

Feat. A. de la Fuente
16:56
Current Challenges in Hematology

Targeting Inflammation in LR-MDS

Feat. A. Sophie Kubasch
16:39
Current Challenges in Hematology

LR-MDS 2023: Standards and Perspectives

Feat. U. Platzbecker
15:49
Current Challenges in Hematology

AML in 2023: How Do Cancer Genomics Guide Therapeutic Choices?

Feat. M. Teresa Voso
16:57
Current Challenges in Hematology

How I Treat CML in Advanced Phases

Feat. G. Saglio
30:15
Current Challenges in Hematology

What's New Beyond 1L Treatment in CML: Ponatinib

Feat. G. Rosti
22:15
Current Challenges in Hematology

Efficacy of BCMA-Targeted Therapies in Pretreated Patients With R/R …

Feat. C. Cerchione
17:32
Current Challenges in Hematology

Patient Journey for a Transplant-Ineligible Patient With MM From 1L …

Feat. R. Mina
31:28
Current Challenges in Hematology

Current Treatment Strategies in MM: Overcoming Incurability

Feat. M. Mateos
20:59
Current Challenges in Hematology

Patient Journey for a Transplant-Eligible Patient From 1L to Subsequ…

Feat. E. Zamagni
18:48
Current Challenges in Hematology

Venetoclax-Based Combinations in Newly Diagnosed AML: A New Golden S…

Feat. C. DiNardo
12:27
Current Challenges in Hematology

What's New Beyond 1L Treatment in CML: Asciminib

Feat. M. Breccia